STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (32,194,303)	$ (36,700,681)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	3,958,334	3,828,917
Non-cash lease expense	15,292	54,469
Share-based payments for services	655,740	762,261
Equity based compensation	6,286,231	11,389,932
Common stock contributed to 401(k) plan	207,593	223,043
Gain on short term investments	0	(615)
Gain on derivative instruments	0	(366,791)
Impairment loss on abandonment of patents	0	30,793
Loss on Receivables	0	54,922
(Increase)/decrease in assets:
Prepaid expenses	151,935	167,651
Supplies used for R&D and manufacturing	(156,727)	(159,430)
Deposits	(2,323,346)	1,910,917
Increase/(decrease) in liabilities:
Accounts payable	257,845	374,890
Accrued expenses	207,089	(16,724)
Due to employees	85,756	205,495
Net cash used in operating activities	(22,848,561)	(18,240,951)
CASH FLOWS FROM INVESTING ACTIVITIES:
Proceeds from maturity of U.S. Treasury Bills	0	6,152,000
Purchases of property and equipment	(361,892)	(637,892)
Expenditures for patent costs	(10,370)	(22,741)
Net cash (used in) provided by investing activities	(372,262)	5,491,367
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock	6,552,497	0
Payments of stock issuance costs	(744,913)	(169,445)
Proceeds from the exercise of warrants	447,291	101,225
Proceeds from the exercise of options	0	29,835
Proceeds from landlord funding of lease improvements	0	786,454
Payments on obligations under finance leases	(1,560,455)	(1,386,495)
Net cash provided by (used in) financing activities	4,694,420	(638,426)
NET DECREASE IN CASH AND CASH EQUIVALENTS	(18,526,403)	(13,388,010)
CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR	22,672,138	36,060,148
CASH AND CASH EQUIVALENTS, END OF YEAR	4,145,735	22,672,138
SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Property and equipment purchases included in current liabilities	51,650	0
Capitalized patent costs included in current liabilities	13,211	0
Assets purchased under finance leases	0	32,409
Changes to right of use assets and liabilities	0	16,268
Finance lease obligation included in accounts payable	1,451	1,354
Prepaid consulting services paid with issuance of common stock	565,980	295,143
Financing costs included in current liabilities	77,703	9,010
Exercise of derivative liabilities	0	70,589
Accrued consulting services to be paid with common stock	55,000	55,000
Cash paid for interest	$ 1,062,564	$ 1,157,069